Filing Flows › Viridian Therapeutics (VRDN) › How it makes money
How Viridian Therapeutics (VRDN) makes money
Viridian Therapeutics (VRDN) made $25.8M of revenue in the third quarter 2026 (Q3 2026), -64% from a year earlier. Product revenue, net brought in $24.7M (96%); Collaboration revenue brought in $956K (4%); License revenue brought in $125K (0%).
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Product revenue, net | $24.7M | 95.8% | — | — |
| Collaboration revenue | $956K | 3.7% | — | +68% |
| License revenue | $125K | 0.5% | — | -100% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $25.8M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $25.8M | -64% |
| Q2 2026 | $284K | +279% |
| Q1 2026 | $141K | +96% |
| Q4 2025 | $132K | +83% |
| Q3 2025 | $70.6M | 821× |
| Q2 2025 | $75K | +4% |
| Q1 2025 | $72K | 0% |
From Viridian Therapeutics' 10-Q filed Nov 4, 2026 (on EDGAR).
Questions
How does Viridian Therapeutics make money?
Viridian Therapeutics (VRDN) made $25.8M of revenue in the third quarter 2026 (Q3 2026), -64% from a year earlier. Product revenue, net brought in $24.7M (96%); Collaboration revenue brought in $956K (4%); License revenue brought in $125K (0%).
What is Viridian Therapeutics' biggest business?
Product revenue, net: $24.7M in the third quarter 2026, 96% of revenue.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.